EP1666500

Use of trifunctionel antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    1.12.2004
  • :
    21.9.2011
  • :
    04028473.9
  • :
    Use of trifunctionel antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy

1.12.2004
21.9.2011
  • :
    TRION PHARMA GMBH
  • :
    Frankfurter Ring 193a, 80807, München, DE
  • :
    Lindhofer, Horst, Dr.
  • :
    München, DE
  • :
    Morecki, Shoshana
  • :
    Jerusalem, IL
  • :
    Slavin, Shimon
  • :
    Jerusalem, IL
  • :
    C07K 16/28, C07K 16/32, C07K 16/30, A61K 35/14, A61P 35/02